Article Text

PDF

007
THE ROLE OF CHRONIC INFLAMMATION ON AMYLOID BURDEN IN MS
  1. E Ridgeon,
  2. A Gutnikova,
  3. G Colquhoun,
  4. R Hickman,
  5. MM Esiri,
  6. GC De Luca
  1. University Of Oxford

Abstract

Alzheimer's disease (AD) is a degenerative disorder wherein β-amyloid deposition and inflammation are key pathological features. The complex interplay between inflammation and β-amyloid burden in AD is becoming increasingly recognised. To evaluate the influence of chronic inflammation on β-amyloid deposition, a cohort of pathologically confirmed multiple sclerosis (MS) cases (n=67) was compared to non-demented age- and sex-matched controls (n=55). Formalin-fixed paraffin embedded cortical tissue from the mesial temporal gyrus was immunostained for β-amyloid and myelin. Quantitative measures of β-amyloid burden in MS normal appearing grey matter (NAGM) and cortical lesions were compared to those derived from control NAGM. MS cases lying at the extremes of β-amyloid burden (n=25) were additionally immunostained for microglial inflammation. Preliminary data showed that β-amyloid burden was significantly reduced in MS NAGM compared to controls (p=0.08), with MS cortical lesions demonstrating significantly less β-amyloid compared to MS NAGM (p<0.01), particularly at the lesional border. Microglial activation was significantly less in the high compared to low amyloid groups (p<0.05). These findings suggest the chronic inflammatory milieu in the MS brain protects against β-amyloid deposition, with microglial activation playing a central role. Studies evaluating the relationship between MS-specific microglial activation and amyloid processing are warranted.

  • EPILEPSY

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.